Atrovastatin-PEG3-FITC structure
|
Common Name | Atrovastatin-PEG3-FITC | ||
|---|---|---|---|---|
| CAS Number | 1440755-31-6 | Molecular Weight | 1150.31 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C64H68FN5O12S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Atrovastatin-PEG3-FITCAtrovastatin-PEG3-FITC (compound S31) is a KRAS-PDEδ interaction inhibitor. Atrovastatin-PEG3-FITC acts as a ligand in fluorescence anisotropy assay[1][2]. |
| Name | Atrovastatin-PEG3-FITC |
|---|
| Description | Atrovastatin-PEG3-FITC (compound S31) is a KRAS-PDEδ interaction inhibitor. Atrovastatin-PEG3-FITC acts as a ligand in fluorescence anisotropy assay[1][2]. |
|---|---|
| Related Catalog | |
| Target |
KRAS-PDEδ |
| References |
| Molecular Formula | C64H68FN5O12S |
|---|---|
| Molecular Weight | 1150.31 |
| InChIKey | WHWNHUTWCMCCLV-YYACYCFASA-N |
| SMILES | CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(O)CC(O)CC(=O)NCCCOCCOCCOCCCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21 |